Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-07-20 19:02 CEST (UTC+2h)

Brexit [BE/BA News]

posted by Helmut Homepage - Vienna, Austria, 2017-12-12 12:50  - Posting: # 18059
Views: 993

Dear all,

the EC’s Directorate-General Health and Food Safety and the EMA published Rev 01 of

Questions and Answers related to the United Kingdom’s
withdrawal from the European Union with regard to the medicinal
products for human and veterinary use within the framework of
the Centralised Procedure

11. Can medicinal products used in bioequivalence studies be sourced in the UK?
[…] Bioequivalence studies that have been conducted with a medicinal product sourced in the UK can be used in generic/hybrid marketing authorisation applications only if the marketing authorisation for that application will be granted before 30 March 2019.*



Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,547 posts in 3,941 threads, 1,191 registered users;
online 18 (1 registered, 17 guests [including 8 identified bots]).

If there is an exception to any rule,
and if it can be proved by observation,
that rule is wrong.    Richard Feynman

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed